dc.contributor.author | Bertsimas, Dimitris | |
dc.contributor.author | Boussioux, Leonard | |
dc.contributor.author | Cory-Wright, Ryan | |
dc.contributor.author | Delarue, Arthur | |
dc.contributor.author | Digalakis, Vassilis | |
dc.contributor.author | Jacquillat, Alexandre | |
dc.contributor.author | Kitane, Driss L. | |
dc.contributor.author | Lukin, Galit | |
dc.contributor.author | Li, Michael | |
dc.contributor.author | Mingardi, Luca | |
dc.contributor.author | Nohadani, Omid | |
dc.contributor.author | Orfanoudaki, Agni | |
dc.contributor.author | Papalexopoulos, Theodore | |
dc.contributor.author | Paskov, Ivan | |
dc.contributor.author | Pauphilet, Jean | |
dc.contributor.author | Lami, Omar S. | |
dc.date.accessioned | 2021-11-01T14:33:42Z | |
dc.date.available | 2021-11-01T14:33:42Z | |
dc.date.issued | 2021-02-15 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/136840 | |
dc.description.abstract | Abstract
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast. | en_US |
dc.publisher | Springer US | en_US |
dc.relation.isversionof | https://doi.org/10.1007/s10729-020-09542-0 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-Share Alike | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
dc.source | Springer US | en_US |
dc.title | From predictions to prescriptions: A data-driven response to COVID-19 | en_US |
dc.type | Article | en_US |
dc.contributor.department | Sloan School of Management | |
dc.contributor.department | Massachusetts Institute of Technology. Operations Research Center | |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2021-06-29T03:37:51Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature | |
dspace.embargo.terms | Y | |
dspace.date.submission | 2021-06-29T03:37:51Z | |
mit.license | OPEN_ACCESS_POLICY | |
mit.metadata.status | Authority Work and Publication Information Needed | |